Product Information
PHENTERMINE 30 MG CAPSULE is a generic product labeled by Sunrise Pharmaceutical Inc., priced at $0.1220 per EA under NDC 11534017603. Its NADAC has been published 372 times since May 15, 2019.
Strength
30 mg/1
Manufacturer
Sunrise Pharmaceutical Inc.NDC
11534017603
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PHENTERMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205019On Market Since
1/24/2017
Pharmacological Classes
Price Statistics
The NADAC for PHENTERMINE 30 MG CAPSULE has been published 372 times since May 15, 2019, and over the history we have for it it has declined 25.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1220 per EA |
|---|---|
| All-time high | $0.1988 (Dec 13, 2023) |
| All-time low | $0.0923 (Mar 18, 2026) |
| 52-week high | $0.1263 |
| 52-week low | $0.0923 |
| Median price | $0.1361 |
| Average price | $0.1377 |
| Largest weekly change | +58.1% (Mar 20, 2024) |
| Weeks tracked | 372 |
| Tracking since | May 15, 2019 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of PHENTERMINE 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for PHENTERMINE 30 MG CAPSULE, manufactured by Sunrise Pharmaceutical Inc., is $0.1220 per EA (NDC 11534017603), effective Jun 24, 2026.
How has the price of PHENTERMINE 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for PHENTERMINE 30 MG CAPSULE has declined 25.0%. It has been tracked across 372 weekly CMS publications since May 15, 2019.
What are the highest and lowest recorded NADAC prices for PHENTERMINE 30 MG CAPSULE?
Since May 15, 2019, the NADAC for PHENTERMINE 30 MG CAPSULE has ranged from a low of $0.0923 (Mar 18, 2026) to a high of $0.1988 (Dec 13, 2023), with a median of $0.1361 per EA.
Are there cheaper alternatives to PHENTERMINE 30 MG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as PHENTERMINE 30 MG CAPSULE, but none are currently priced below it.
Who manufactures PHENTERMINE 30 MG CAPSULE?
PHENTERMINE 30 MG CAPSULE (NDC 11534017603) is labeled by Sunrise Pharmaceutical Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification